US$ 22.86
fda approval status of cjc-1295 ipamorelin bpc-157 tb-500 aod-9604 CJC-1295+Ipamo The Peptide Craze - Ground
Description
Although published studies and reviews discuss promising activity in preclinical models, available human data remain limited, and findings from animal or cell studies should not be directly translated into human outcomes

SC: Max 10mg/day, 30mg/week

An absolutely amazing experience from start to finish

Individual results vary

AOD 9604, is considered safe under medical direction
